Our data show that VEGF blockade leads to an increased recruitment of monocytes and to an adjustment of dendritic cell subsets’ profiles, differing in their ability to induce an adaptive immune response. Altogether, they provide important new insights into the effects of Bevacizumab at the cellular level and into the spatio-temporal evolution of intra-tumoral innate immune cell densities.

Le principal journal à comité de lecture consacré à la compréhension de l'impact vital des processus d'oxygénation et d'oxydo-réduction (redox) sur la santé et les maladies humaines, en explorant les principaux enjeux des thérapies génétiques, pharmaceutiques et nutritionnelles à base de redox.

Pour plus d'informations visitez le site internet d'ARS.

Congratulations to all the CNRS team for running the Marseille-Cassis race two weekends ago, and especially to Claude Villard (7th from the left, top row), INP team 9 and PINT facility member who ran this semi-marathon in 1 hour and 48 minutes.

Next year, let's make a whole INP team (as usual, the race will take place on the last Sunday of October)!

For more information, head to the race's official website.

Lors de la soirée des NeuroStories qui a eu lieu lundi 7 octobre à la faculté de médecine, Anne-Marie François Bellan a livré une prestation remarquée sur la façon dont notre corps vibre au rythme de chronomètres internes appelés horloges circadiennes. Elle a également expliqué comment l’horloge moléculaire utilise des petits corpuscules et l’espace de la cellule pour faire rythmer nos gènes. La vidéo de son intervention ainsi que celles des six autres orateurs seront disponibles très prochainement.

The cIMPACT-NOW Working Committee is the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy. cIMPACT-NOW  was created in late 2016 —following publication of the 2016 Updated 4th Edition of the World Health Organization (WHO) Classification of Tumours of the Central Nervous System— to provide a forum to evaluate and recommend proposed changes to future CNS tumor classifications.

During the 14th EANO annual meeting 3 members of INP team #8 presented their work on Glioma in a plenary conference «CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas» Dominique Figarella Branger, a short talk «Plasmatic differential scanning fluorimetry profiles discriminate glioma patients from healthy controls» Emeline Tabouret and two posters «P11.06: Non epigenetic effect of vorinostat

Nadia Merad Coliac, designer plasticienne, a rejoint l’équipe NOSE (Nasal Olfactory Stemness and Epigenesis) de l’INP, comme chercheuse associée. À la croisée de plusieurs disciplines, elle développe une réflexion et une œuvre expérimentale art et science, dans le domaine de la bioluminescence. Elle envisage une application thérapeutique dans les troubles du spectre autistique (TSA).

We obtained results showing the crucial role of the A2B5 epitope in the promotion of proliferation, migration, clonogenicity, and tumorigenesis of glioblastoma cells, indicating that the glycolipids recognized by the A2B5 antibody are attractive targets for glioblastoma therapy.

Many members of the INP attended the annual Canceropole PACA meeting in the Palais des Congrès of St Raphaël on the 4th and 5th of july. In the frame of the translational research call, F. Devred (INP team 9) & E. Tabouret (INP team 8) presented the results and perspective of their project "Next generation plasma profiling of gliomas using nanoDSF: toward a new prognostic and monitoring tool"

Full program available here.

INP team 8 and 9 and PINT members being part of the French Microtubule Network, several members presented their work at the 4th French Microtubule Network gathering in Rennes on the 1srt and 2nd july 2019, in the  "Microtubules and their regulators : new therapeutic targets" session and the "Microtubules, assembly and regulation" session.